Understanding the factors that increase or reduce costs and the ways that payments affect the choices people make can help improve health and health care decision making.
In a recent webinar in collaboration with the National Pharmaceutical Council, experts discussed how to evaluate SDOH programs and interventions from a cost perspective. Speakers emphasized the incomplete state of current knowledge and the need to improve studies and data infrastructure to determine their value.
This webinar was part of series which seeks to promote serious evidence-based discussions related to costs, value, and allocation of health care spending.
Date & Time May 4, 2021 | 3:00 p.m. - 4:00 p.m. ET
Location Online
Reflecting upon the 2019 Summit, “Imagining a World Without Low-Value Care: What Will it Take?” sponsored by AcademyHealth, the Donaghue Foundation, and the ABIM Foundation, in collaboration with the Kaiser Permanente Center for Total Health and the Veterans Administration, a commentary published in the American Journal of Managed Care explores the main barriers preventing progress against low-value care and highlights promising solutions.
In October 2019, researchers, policy experts, practicing physicians, funders, and other key stakeholders gathered for a summit to develop recommendations for reducing low-value care.
In a recent webinar for the Research Community on Low-Value Care, experts shared what their organizations have learned about building organizational resilience, recovery, and capacity during COVID-19. Speakers emphasized the need to re-design our health systems around high-value care, equity, and more stable payment structures.
As partners in the Going Below The Surface Forum, AcademyHealth and the National Pharmaceutical Council (NPC) consider the drivers of health spending in the United States through salons focused on challenging questions – which may not have immediate or universally accepted answers – as we attempt to push the conversation beyond the usual stakeholder posturing.
Medical care providers recognize the importance of discussing cost of care issues with their patients but have struggled to incorporate these conversations into clinical practice. This second of two posts focuses on integrating cost of care discussions into the clinical flow.
This is the first of a two-part series focused on the importance of screening for and addressing cost of care issues for patients and caregivers. It addresses both the obstacles and opportunities for incorporating cost of care discussions into clinical practice.
Summarizing an expert discussion at an August 2020 virtual meeting, this brief examines the COVID-19 vaccine development experience and reviews existing research on vaccine development, manufacturing, and distribution, including financing mechanisms to help ensure its accessibility, as well as policies to promote equity.
As the COVID-19 pandemic shines a spotlight on the critical role of nursing in health care delivery, members from the Interdisciplinary Research Group on Nursing Issues (IRGNI) highlight key areas of focus to ensure nursing health services research is well-positioned to address the nation’s top health care challenges over the next decade.
